3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 2.940
0.00 (0.00%)
Jun 17, 2026, 1:29 PM HKT
3D Medicines Market Cap
3D Medicines has a market cap or net worth of 723.01 million as of June 17, 2026. Its market cap has decreased by -26.21% in one year.
Market Cap
723.01M
Enterprise Value
348.01M
Revenue
396.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.94
Market Cap Chart
Since December 15, 2022, 3D Medicines's market cap has decreased from 7.02B to 723.01M, a decrease of -89.71%. That is a compound annual growth rate of -47.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 723.01M | -44.72% |
| Dec 31, 2025 | 1.31B | 73.29% |
| Dec 31, 2024 | 754.73M | -56.44% |
| Dec 29, 2023 | 1.73B | -81.75% |
| Dec 30, 2022 | 9.49B | 35.14% |
| Dec 15, 2022 | 7.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 1.16B |
| Cloudbreak Pharma | 1.04B |
| Sunho Biologics | 970.43M |
| Wuhan YZY Biopharma | 814.17M |
| Brii Biosciences | 729.03M |
| JW (Cayman) Therapeutics Co. | 694.08M |
| Shanghai Bio-heart Biological Technology | 657.23M |
| Transcenta Holding | 597.30M |